Dr Scott C Cole, MD | |
2010 Health Campus Dr, Harrisonburg, VA 22801-8679 | |
(540) 689-1110 | |
(540) 689-1119 |
Full Name | Dr Scott C Cole |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 2010 Health Campus Dr, Harrisonburg, Virginia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063484947 | NPI | - | NPPES |
183899 | Other | VA | ANTHEM- STRASBURG |
292395 | Other | VA | ANTHEM- WOODSTOCK |
010203261 | Medicaid | VA | |
020620218 | Other | VA | TAX ID# |
006736190 | Medicaid | VA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 0101052556 (Virginia) | Primary |
Entity Name | Privia Medical Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20140603000011 |
News Archive
Sequencing a patient's entire genome to discover the source of his or her disease is not routine - yet. But geneticists are getting close. A case report, published this week in the American Journal of Human Genetics, shows how researchers can combine a simple blood test with an "executive summary" scan of the genome to diagnose a type of severe metabolic disease.
Anacor Pharmaceuticals announced today that it has completed the enrollment of approximately 600 patients in the second of its two Phase 3 trials of tavaborole, a topical anti-fungal product candidate for the treatment of onychomycosis, a fungal infection of the nail and nail bed that affects approximately 35 million people in the United States.
Any time life hands us a stressful situation, we have a decision to make: will we handle it with grace, or let it pile up on everything else? For women, stress sometimes feels like a never-ending occurrence, and University of Alabama at Birmingham experts say that, left unmanaged, stress can lead to health problems. But it can easily be curtailed.
Can-Fite BioPharma Ltd, a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened Investigational New Drug application (IND) with the United States Food and Drug Administration (US FDA). The IND is for Can-Fite's lead compound, CF101, for the treatment of patients with psoriasis. This is the third US IND for CF101, and the fourth for Can-Fite.
Ardelyx, Inc., a clinical-stage company focused on enhancing the treatment of patients with gastrointestinal and cardiorenal diseases, today announced the initiation of a Phase 3 clinical trial and an onset-of-action clinical trial evaluating RDX7675 in patients with hyperkalemia, a potentially life-threatening condition common in patients with cardiorenal disease.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Scott C Cole, MD Po Box 1430, Harrisonburg, VA 22803-1430 Ph: (540) 564-7084 | Dr Scott C Cole, MD 2010 Health Campus Dr, Harrisonburg, VA 22801-8679 Ph: (540) 689-1110 |
News Archive
Sequencing a patient's entire genome to discover the source of his or her disease is not routine - yet. But geneticists are getting close. A case report, published this week in the American Journal of Human Genetics, shows how researchers can combine a simple blood test with an "executive summary" scan of the genome to diagnose a type of severe metabolic disease.
Anacor Pharmaceuticals announced today that it has completed the enrollment of approximately 600 patients in the second of its two Phase 3 trials of tavaborole, a topical anti-fungal product candidate for the treatment of onychomycosis, a fungal infection of the nail and nail bed that affects approximately 35 million people in the United States.
Any time life hands us a stressful situation, we have a decision to make: will we handle it with grace, or let it pile up on everything else? For women, stress sometimes feels like a never-ending occurrence, and University of Alabama at Birmingham experts say that, left unmanaged, stress can lead to health problems. But it can easily be curtailed.
Can-Fite BioPharma Ltd, a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened Investigational New Drug application (IND) with the United States Food and Drug Administration (US FDA). The IND is for Can-Fite's lead compound, CF101, for the treatment of patients with psoriasis. This is the third US IND for CF101, and the fourth for Can-Fite.
Ardelyx, Inc., a clinical-stage company focused on enhancing the treatment of patients with gastrointestinal and cardiorenal diseases, today announced the initiation of a Phase 3 clinical trial and an onset-of-action clinical trial evaluating RDX7675 in patients with hyperkalemia, a potentially life-threatening condition common in patients with cardiorenal disease.
› Verified 8 days ago
Dr. Tara H Prieur, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1947 Medical Ave, Harrisonburg, VA 22801 Phone: 540-434-3004 Fax: 540-343-3659 | |
Oluwatosin Oladeinde, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 1479 Virginia Ave, Harrisonburg, VA 22802 Phone: 540-433-4913 | |
Megan Elizabeth Imholt, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2034 Pro Pointe Ln, Harrisonburg, VA 22801 Phone: 540-217-5333 Fax: 540-217-5328 | |
Dr. Christopher A Ashton, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1947 Medical Ave, Harrisonburg, VA 22801 Phone: 540-434-3004 Fax: 540-433-2540 | |
Dr. Frank W Gearing, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1947 Medical Ave, Harrisonburg, VA 22801 Phone: 540-434-3004 Fax: 540-433-2540 | |
Dr. Erika L Shelburne, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2010 Health Campus Dr, Harrisonburg, VA 22801 Phone: 540-689-1000 |